Fig. 2From: Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sourcesPRISMA diagram. *Countries of interest: Australia, Brazil, Canada, China, Denmark, Finland, France, Germany, Iceland, Italy, Japan, Norway, Spain, Sweden, the UK and the USA. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-AnalysesBack to article page